Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sensys Medical
AddedFeb 17, 2024
UpdatedJun 18, 2026
Sensys Medical

Sensys Medical

Series D

Sensys Medical: Non-invasive blood glucose tracking system developer based in Chandler, Arizona.

HQ
Chandler, AZ, US
Founded
1995
Overview
Compare
Fundraising
Employees

Sensys Medical develops non-invasive blood glucose measurement devices for individuals with diabetes. The company offers a tracking system that measures glucose levels without the need for blood samples. Sensys Medical is based in Chandler, Arizona, and focuses on improving diabetes management through innovative technology.

Sensys Medical has achieved significant advancements in non-invasive glucose monitoring, providing a more comfortable and convenient solution for diabetes patients. The company's impact lies in enhancing the quality of life for users by reducing the discomfort and inconvenience associated with traditional blood glucose testing methods.

Sensys Medical - Similar Companies

Senseonics Holdings logo

Senseonics Holdings

senseonics.com

Glysens logo

Glysens

GlucoVista logo

GlucoVista

glucovista.com

Channel Medsystems logo

Channel Medsystems

Glumetrics logo

Glumetrics

BioSensys logo

BioSensys

C8 Medisensors logo

C8 Medisensors

Integrated Medical Sensors logo

Integrated Medical Sensors

Accurate Medical Systems logo

Accurate Medical Systems

Oculir logo

Oculir

InLight Solutions logo

InLight Solutions

Dexcom logo

Dexcom

dexcom.com

MediSens logo

MediSens

medisens.com

Intuity Medical logo

Intuity Medical

presspogo.com

Diramed logo

Diramed

Sensys Medical - Quick Facts

Who are Sensys Medical's competitors?

Companies similar to Sensys Medical include Senseonics Holdings, Glysens, GlucoVista and Channel Medsystems.

When was Sensys Medical founded?

Sensys Medical was founded in 1995.

Where is Sensys Medical's headquarters located?

Sensys Medical's headquarters is located in Chandler, AZ, US.

When was Sensys Medical's last funding round?

Sensys Medical's most recent funding round was for $31M (USD) in July 2002.

How much has Sensys Medical raised to-date?

As of Jul 31, 2002, Sensys Medical has raised a total of $31M (USD).

How many employees does Sensys Medical have?

Sensys Medical has 6 employees as of Feb 5, 2024.

Sensys Medical - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Analytics
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Medical Devices
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified